Biovie is trading at $2.30, up +6.48% in pre-market amid reported insider purchases.
- Multiple insiders reported purchases after the August 28 session, including CEO Cuong V. Do, CFO Joanne Kim, director Amy Chappell, and CMO Joseph Palumbo.
- CEO Do purchased 15,210 shares worth $31,636; the other three insiders bought shares totaling approximately $17,481.
- These filings are the clearest overnight development, but reports do not establish that insider buying caused the gain. Broader markets were mixed.